The Core Eligibility Requirements
To have a viable Suboxone dental injury claim, you generally need to satisfy four primary criteria. First, you must have used Suboxone sublingual film (or a generic buprenorphine/naloxone sublingual film) — not Suboxone sublingual tablets, injectable buprenorphine, or other formulations. The dental injury mechanism is specific to the sublingual film and its acidic excipients. Second, you need to have used the film for a meaningful duration — typically at least six months, though shorter use with significant damage may still support a claim.
Third, you need to have sustained significant dental injuries. Minor dental issues are generally not sufficient. The types of injuries most likely to support a claim include: multiple cavities requiring restorations or crowns; tooth extractions due to decay that progressed beyond restoration; tooth loss requiring implants, bridges, or dentures; need for dental reconstruction; or full-mouth implant-supported restoration. The cost and extent of treatment are important indicators — cases where dental treatment costs exceeded $10,000 are generally more viable. Fourth, your claim must be timely under your state's statute of limitations.
The Role of Your Dental Records
Dental records are the evidentiary backbone of a Suboxone dental injury claim. The most compelling cases have dental records that clearly show: healthy or reasonably healthy dentition before Suboxone use began; development of new or rapidly worsening dental disease during the Suboxone use period; and the type and extent of treatment required to address the decay (restorations, extractions, implants, etc.). Dental X-rays are particularly valuable because they provide visual, objective evidence of decay that progressed during treatment. If your dentist noted anything unusual about the pattern or rate of your decay, those treatment notes are important evidence. Request your complete dental records as soon as possible — dental practices are required to retain records for a minimum number of years that varies by state, and older records may be difficult to obtain from practices that have closed or transitioned ownership.
Cases That May Not Qualify
Certain situations make a claim less viable. Cases involving only minor dental issues — a single cavity, routine sensitivity, or isolated gum irritation — are generally not sufficient to support a claim given the cost and risk of litigation. Claims where the patient had significant pre-existing dental disease that makes it difficult to separate Suboxone-caused damage from pre-existing conditions may face causation challenges, though they are not automatically disqualified. Claims where the dental records are incomplete or unavailable are more difficult to pursue, though an attorney may be able to work with partial records. Claims that appear to be outside the statute of limitations require individual legal analysis — do not assume your claim is time-barred without consulting an attorney, particularly given the January 2022 FDA communication and its potential effect on the discovery rule in your state.
Frequently Asked Questions
Related Pages
Suboxone Dental Damage Explained
Suboxone sublingual film strips damage teeth through a chemical acid erosion mechanism. Citric acid in the film creates a highly acidic oral environment during dissolution, dissolving tooth enamel with repeated daily exposure. This process is distinct from ordinary tooth decay and produces a characteristic pattern of rapid, widespread, smooth-surface erosion that dentists can document in dental records.
Suboxone Statute of Limitations by State
Suboxone dental injury claims are subject to state product liability statutes of limitations, typically 2 to 3 years, which may run from the January 12, 2022 FDA safety communication under the discovery rule. Deadlines vary significantly by state and individual circumstances — time is critical and consultation with an attorney is the only reliable way to determine your specific deadline.
Suboxone Dental Records and Evidence Gathering
Dental records — including clinical notes, X-rays, and billing documentation — are the evidentiary foundation of every Suboxone dental injury claim. Gathering them promptly is critical because dental practices have limited record retention requirements and older records may be unavailable from closed or sold practices.
Suboxone Settlement Amounts and Expectations
Reported Suboxone dental injury settlements have ranged from approximately $35,000 for minor-to-moderate cases to $250,000 or more for complete tooth loss requiring full-mouth reconstruction. The MDL is ongoing and no global settlement has been announced — individual case values depend heavily on injury severity, documentation quality, and state-specific legal factors.
Indivior's Failure to Warn
Indivior, the manufacturer of Suboxone, had access to medical literature and adverse event data establishing the dental risk of its sublingual film formulation for years before adding dental warnings to its label. Under pharmaceutical product liability law, this gap between knowledge and disclosure forms the foundation of the failure-to-warn claims at the center of Suboxone dental injury litigation.
The FDA Suboxone Dental Warning — January 2022
On January 12, 2022, the FDA issued a formal drug safety communication confirming that buprenorphine medicines dissolved in the mouth — including Suboxone film — can cause severe dental problems. The FDA reviewed 305 adverse event reports and found widespread, serious dental injuries requiring extractions, root canals, and full reconstruction. This communication is legally significant as the potential trigger date for the statute of limitations under the discovery rule for thousands of patients.
Suboxone vs. Generic Buprenorphine Film
The dental injury risk from buprenorphine sublingual film is not unique to the Suboxone brand — generic buprenorphine/naloxone sublingual films share the same acidic excipient mechanism and the same dental injury profile. However, pursuing claims against generic manufacturers involves different legal considerations than brand-name product liability claims under both federal and state law.
Suboxone Dental Treatment Costs
Dental rehabilitation costs for Suboxone-related injuries can range from several thousand dollars for restorations to $80,000 or more for full-mouth implant-supported reconstruction. These documented costs form the economic damages component of a claim and are recoverable in litigation. Understanding the cost breakdown helps patients evaluate the potential value of their claim.
How to File a Suboxone Dental Injury Lawsuit
Filing a Suboxone dental injury lawsuit begins with gathering dental and prescription records, consulting a pharmaceutical litigation attorney, and submitting a complaint. Most cases are filed in or transferred to MDL 3092 in the Northern District of Ohio. The process is handled almost entirely by the attorney, with no upfront costs under a contingency fee arrangement.
Suboxone Class Action vs. Individual Claims
Suboxone dental injury litigation is structured as a multidistrict litigation (MDL), not a class action. In an MDL, plaintiffs retain individual claims and individual damages — each client's recovery is based on their specific injuries, not shared with others. Understanding this distinction helps plaintiffs know what to expect from the process.
MAT Patients and Dental Stigma
People in recovery from opioid use disorder who experienced Suboxone-related tooth loss face a unique double stigma: societal bias against addiction, and the unfair association between visible tooth loss and substance use. These psychological and social harms are legally compensable non-economic damages, and addressing them with compassion and dignity is central to how these cases should be litigated.
Suboxone Tooth Decay Lawsuit
Suboxone sublingual film strips — a medication-assisted treatment (MAT) for opioid use disorder — dissolve under the tongue and contain citric acid and other acidic excipients that, with repeated use, erode tooth enamel and cause rapid, severe dental decay. Thousands of patients who faithfully took Suboxone as prescribed to manage opioid dependence later discovered they had lost multiple teeth, required extensive dental reconstruction, or faced thousands of dollars in oral surgery costs — through no fault of their own. Manufacturer Indivior (formerly part of Reckitt Benckiser) knew or should have known about these dental risks for years but failed to include adequate warnings on the product label. The FDA confirmed the danger with a formal safety communication on January 12, 2022, requiring updated product labeling. Patients who suffered dental injuries while using Suboxone sublingual film may have valid product liability claims against Indivior for failure to warn.
View full case overview